| Term 
 
        | NT: Acetylcholine Biosynthesis Pathway |  | Definition 
 
        | Choline + Acetyl CoA---> Acetylcholine + CoEnzyme A Produced by Motor Neurons
 |  | 
        |  | 
        
        | Term 
 
        | Acetylcholine Biosynthesis: Enzyme |  | Definition 
 
        | Choline Acetyltransferase |  | 
        |  | 
        
        | Term 
 
        | NT: Acetylcholine Degradation
 |  | Definition 
 
        | Acetylcholine---> Acetic Acid + Choline |  | 
        |  | 
        
        | Term 
 
        | Acetylcholine Degradation: Enzyme |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1)Nicotinic Cholinergic Receptors 2)Muscarinic Cholinergic Receptors
 Located in the Brain
 |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Receptors: a)Related to which NT?
 b)What is its role?
 c)If agonist added?
 d)If antagonist added?
 e) Type:
 |  | Definition 
 
        | a)Acetylcholine b)Cognition/ Movement
 c)Increase in AcH release-->Muscle Contraction
 d)Decrease in AcH release--->
 Paralysis/Weakness
 e) G Coupled Protein
 |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Agonists Effects (5) |  | Definition 
 
        | 1) Heart Rate (Decr) 2) GI Tract: Diaherrea
 3) Salivation
 4) Contraction of Diaphragm
 5) Increase AcH levels: Alertness
 |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Antagonists Effects (4) |  | Definition 
 
        | 1) Stop breathing 2) Heart Rate (Incr)
 3) Blood Pressure (Incr)
 4) Decrease AcH in Brain : Drowsiness
 |  | 
        |  | 
        
        | Term 
 
        | Muscarinic Receptors: a)Related to which NT?
 b)What is its role?
 c)If agonist added?
 d)If antagonist added?
 e) Type:
 |  | Definition 
 
        | a) Acetylcholine b) Learning, Memory, Arousal
 c)Parasympathetic Effects
 d) Sympathetic Effects
 e) Ligand- gated Ion Channel
 |  | 
        |  | 
        
        | Term 
 
        | Acetylcholine Location/Pathways |  | Definition 
 
        | Nucleus Basalis a)Axons project to Neocortex
 |  | 
        |  | 
        
        | Term 
 
        | NT: Dopamine Biosynthesis Pathway
 |  | Definition 
 
        | Tyrosine--->DOPA--->Dopamine |  | 
        |  | 
        
        | Term 
 
        | Dopamine Biosynthesis: Enzyme |  | Definition 
 
        | Tyrosine Hydroxylase (TH) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1)D1 2)D2 Post and Pre Synaptic
 G-Coupled Protein Receptors
 |  | 
        |  | 
        
        | Term 
 
        | Dopamine Location/Pathways |  | Definition 
 
        | Dorsal Striatum--->Substantia Nigra Ventral Striatum---> Ventral Tegmental
 |  | 
        |  | 
        
        | Term 
 
        | Dorsal Striatum a)Related to which NT?
 b)What is its role?
 Info
 |  | Definition 
 
        | a) Dopamine b)Motor Control
 Degeneration--->Problems w/ Initiating of Movement--->Tremor/Paralysis
 |  | 
        |  | 
        
        | Term 
 
        | Ventral Striatum a)Related to which NT?
 b)What is its role?
 Info
 c)If agonist added?
 d)If antagonist added?
 e) Type:
 |  | Definition 
 
        | a)Dopamine b)Reward/Appetitive Motivation
 Addition Pathway
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hyperactivity of Dopamine in Ventral Pathways |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Motor Activation (Decr) Reward/ Motivation (Decr)
 Depression Like Symptoms
 Parkinson's Like
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Motivation/ Cravings (Incr) Motor Activation (Incr)
 Stereotypy: Repetitive Motor Behavior
 Schizophrenic Like
 |  | 
        |  | 
        
        | Term 
 
        | NT: Norephinephrine Biosynthesis Pathway
 |  | Definition 
 
        | Tyrosine--->DOPA--->Dopamine---> Noephinephrine
 |  | 
        |  | 
        
        | Term 
 
        | Norephinephrine Location/Pathways |  | Definition 
 
        | Locus Coeruleus Projects throughout the Brain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activation of Arousal a) Shut off when sleep: sleep
 b) Maximized when stress:anxiety
 c) Hunger and Eating Behavior
 d) Pain and Fear
 |  | 
        |  | 
        
        | Term 
 
        | Noephrinephine: Receptors |  | Definition 
 
        | 1) Alpha Adrenergic Receptors a)Alpha 2: Autoreceptor sedative and analgesic
 b)Agonist decrease NE Activity
 2) Beta Adrenergic Receptors
 b)Beta Blocker used to decrease heart rate and blood pressure
 b) Agonist: shutdown LC Activity---> Sedative, anti-anxiety
 |  | 
        |  | 
        
        | Term 
 
        | NT: Serotonin Biosynthesis Pathway |  | Definition 
 
        | L-Tryptophan--->L-5-Hydroxytrytophan---> 5-HT (serotonin) |  | 
        |  | 
        
        | Term 
 
        | Serotonin: Location/Pathways |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tryptophan: Mood Regulation |  | Definition 
 
        | Incr Trypt---> Better Mood Decr Trypt---> Depression (not in healthy individuals)
 |  | 
        |  | 
        
        | Term 
 
        | Serotonin: Mood Regulation |  | Definition 
 
        | High 5-HT--> High Tryptophan--> Anxiety--> decreased appetite Deficit= Poor impulse control
 agressiveness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) GABA(a) Receptors a)Ionotrophic: Ion Channels
 2) GABA(b) Receptors
 b)Metabotropic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a)Ion Channels b)5 Subunits
 c)Muscimol: Hallucinogenic Effects
 High Doses: Sympathetic Effects
 d)Sensitive to CNS Depressant Drugs Such as Ethanol and Benzodiazopines and Barbituates
 e)Agonist Diazepam: sedative
 f) Inverse Agonist: Opposite effect of agonist, though doesn't block like antagonist, Anxiety producing, arousing
 g) Neurosteroids: Enhance GABA(a) receptor function-->sedative
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ionotropic: 1)Kainate
 2)NMDA (na+ and ca2+)
 
 --->Creates ESPS caused by the flow of Na+ into cell
 
 - Receptor channels can be blocked by Mg2+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ionotropic: 1)Kainate
 2)NMDA (na+ and ca2+)
 
 --->Creates ESPS caused by the flow of Na+ into cell
 
 - Receptor channels can be blocked by Mg2+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | High Levels: Toxic: Excitotoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stress induced analgesia Incr Peptide Decr pain
 Morphine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Corticotropin Releasing Factor |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | THC Drug Development
 Antiemtic Effects
 |  | 
        |  |